All stock lists
Banco Bilbao Vizcaya Argentaria (New York Stock Exchange:BBVA)
ES · Delayed Price · Currency is USD
Financial Services · Banks - Diversified
25.24-0.10 (-0.39%)
Market cap
$139B
Insider Score
Health Score
Analyst consensus
Listed since
Dec 15, 1988
Website
Insider Score
––Not scored
BBVA Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Strong
From BBVA’s reported statements · Q2 2026 (trailing 12 months)
Profitability20 / 20
Keeps a healthy share of every dollar it sells.
- Revenue
- $48.85B
- Net income
- $11.12B
- Net margin
- 22.8%
Leverage20 / 20
Little or no net debt.
- Total debt
- $106.16B
- Cash
- $108.52B
- Net debt / EBITDA
- -0.13x
Liquidity0 / 20
Owes more within a year than it holds to pay it.
- Current assets
- $325.42B
- Current liabilities
- $696.16B
- Current ratio
- 0.47
Cash generation20 / 20
The business funds itself from operations.
- Operating cash flow
- $11.43B
- Free cash flow
- $10.08B
- FCF margin
- 20.6%
Dilution & runway20 / 20
Not funding itself by issuing shares.
- Shares outstanding
- 5777.4M
- Share growth (1y)
- 0.1%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
BBVA Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 10.51 B | 10.65 B | 9.79 B | 17.90 B | 8.71 B | 9.32 B |
| Revenue Growth (YoY) | 20.62 % | 14.24 % | 5.10 % | -0.15 % | -5.59 % | 13.44 % |
| Cost of Revenue | 1.68 B | 1.82 B | 1.75 B | 9.69 B | 1.38 B | 9.71 B |
| Gross Profit | 8.83 B | 8.83 B | 8.05 B | 8.21 B | 7.33 B | -383.00 M |
| SG&A Expense | 3.54 B | 3.63 B | 3.58 B | 3.19 B | 2.85 B | 3.18 B |
| R&D Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 3.97 B | 4.11 B | 4.12 B | 4.34 B | 3.26 B | -4.73 B |
| Operating Income | 4.86 B | 4.72 B | 3.93 B | 3.87 B | 4.08 B | 4.35 B |
| Pretax Income | 4.86 B | 4.72 B | 3.93 B | 3.87 B | 4.08 B | 4.35 B |
| Tax Provision | 1.58 B | 1.53 B | 1.27 B | 1.21 B | 1.16 B | 1.47 B |
| Net Income | 3.06 B | 2.99 B | 2.53 B | 2.53 B | 2.75 B | 2.70 B |
| EPS (Basic) | 0.53 | 0.51 | 0.42 | 0.42 | 0.48 | 0.45 |
| EPS (Diluted) | 0.53 | 0.51 | 0.42 | 0.42 | 0.48 | 0.45 |
| Shares Outstanding | 5.78 B | 5.66 B | 5.97 B | 6.03 B | 5.77 B | 5.77 B |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.